| Drug Name |
Sotalol hydrochloride |
| Drug ID |
BADD_D02061 |
| Description |
Sotalol is a methanesulfonanilide developed in 1960.[A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.[L6334] A racemic mixture of sotalol is currently formulated as a tablet, oral solution, and intravenous injection indicated for life threatening ventricular arrhythmias and maintaining normal sinus rhythm in atrial fibrillation or flutter.[Label,L6373,L6376] |
| Indications and Usage |
Sotalol is indicated to treat life threatening ventricular arrhytmias and maintain normal sinus rhythm in patients with atrial fibrillation or flutter.[Label] There are also oral solutions and intravenous injections indicated for patients requiring sotalol, but for whom a tablet would not be appropriate.[Label,L6373,L6376] |
| Marketing Status |
approved |
| ATC Code |
C07AA07 |
| DrugBank ID |
DB00489
|
| KEGG ID |
D01026
|
| MeSH ID |
D013015
|
| PubChem ID |
66245
|
| TTD Drug ID |
D04VMT
|
| NDC Product Code |
12828-0071; 59651-777; 63629-2422; 63629-2423; 70515-105; 70515-119; 76385-115; 58032-0803; 59651-775; 60429-748; 72789-137; 52932-0715; 0093-1062; 42806-122; 0245-0014; 70515-116; 59651-776; 60505-0080; 63187-426; 63629-2421; 69584-842; 71335-0260; 42806-123; 50268-724; 50268-725; 69584-844; 70518-3341; 71205-046; 71610-474; 76385-114; 10920-572; 60429-749; 69584-843; 72789-136; 0093-1061; 0245-0013; 60429-751; 69724-112; 71610-074; 0093-1063; 24338-530; 42806-121; 51655-450; 68084-654; 71335-1917; 72789-138; 76385-116; 0904-7143; 0245-0012; 55154-8179; 60505-0159; 63187-804; 70515-115; 71335-1189; 72789-135; 43353-616; 60429-750; 60505-0081; 60505-0082; 60505-0222; 60505-0223; 60505-0224; 69584-841; 70515-106; 70515-109; 0093-1060; 50090-1299; 0245-0015 |
| UNII |
HEC37C70XX
|
| Synonyms |
Sotalol | Sotalol Hydrochloride | Sotalol Monohydrochloride | MJ-1999 | MJ 1999 | MJ1999 | Darob |
